Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse

Name: Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse
Start: 2021-06-04T13:00:00-04:00
End: 2021-06-04T14:00:00-04:00

Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse

Webinar

Jun 04, 2021 / 01:00PM - 02:00PM EDT

Event Description

A SkylineDx diagnostic test can help identify high-risk myeloma at diagnosis and relapse. Is this test right for you? How can you access it? Learn with us and come with your questions.

SkylineDx is a biotechnology company, focused on the research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam (the Netherlands) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego (California). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of the disease or predict a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient.

Schedule & Agenda

01:00 PM

Introductions

Audrey Burton-Bethke

Audrey welcomes everyone and introduces our featured speaker.

01:00 PM

Introductions

Audrey Burton-Bethke

Audrey welcomes everyone and introduces our featured speaker.

01:05 PM

Presentation

Arjan van Manen

Arjan van Manen presents on SkylineDx and how this biotechnology company can help multiple myeloma patients.

01:05 PM

Presentation

Arjan van Manen

Arjan van Manen presents on SkylineDx and how this biotechnology company can help multiple myeloma patients.

01:30 PM

Q&A

Audience

Ask your questions regarding the presentation and SkylineDx.

01:30 PM

Q&A

Audience

Ask your questions regarding the presentation and SkylineDx.

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Arjan van Manen

Arjan van Manen is the EVP of Business and Commercial Development at SkylineDx BV. He is a strong commercial professional with a track record in Clinical Research, International Marketing Strategy, Market Access, Commercial Excellence Programs, and Business Development. His primary fields of expertise are oncology/ hematology and surgery. He also has experience in the pharmaceutical, medical device, and diagnostic fields. Prior to working at SkylineDx, he worked with organizations including Bristol-Myers Squibb and Takeda Pharmaceuticals. He is fluent in Dutch, German, and English.

Read Bio

Join the Conversation

This event is part of the Disease Progression and Relapsed/Refractory group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.